7 followers
RT @Trankill34: DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas https://t.co/4Xb8bRMGOL
RT @Trankill34: DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas https://t.co/4Xb8bRMGOL
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas https://t.co/4Xb8bRMGOL
DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas. #lymphoma #lymsm https://t.co/ODQhHX3QER
New article: DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas. https://t.co/cfHvXUKnzs #TCL #lymsm #hematology https://t.co/Y8ojNBPP9V